Technical Analysis for CMTA - Clementia Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 11.4 -3.63% -0.43
CMTA closed down 3.63 percent on Friday, December 14, 2018, on 27 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CMTA trend table...

Date Alert Name Type % Chg
Dec 14 Wide Bands Range Expansion 0.00%
Dec 14 Oversold Stochastic Weakness 0.00%
Dec 13 Narrow Range Bar Range Contraction -3.63%
Dec 13 NR7 Range Contraction -3.63%
Dec 13 Wide Bands Range Expansion -3.63%
Dec 13 Oversold Stochastic Weakness -3.63%
Dec 12 50 DMA Resistance Bearish -3.55%
Dec 12 Lower Bollinger Band Walk Weakness -3.55%
Dec 12 Wide Bands Range Expansion -3.55%
Dec 12 Oversold Stochastic Weakness -3.55%

Older signals for CMTA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and activates retinoic acid receptor gamma (an RARg agonist), and has activity in preventing abnormal new bone formation as well as scar tissue formation (or fibrosis) in a variety of tissues in animal models. It is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). Its programs focus on diseases involving tissue transformation via retinoic acid receptors (RARs). The Company also has an eye drop formulation of palovarotene that can potently increase tear production and decrease corneal damage.
Is CMTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.15
52 Week Low 8.1
Average Volume 110,463
200-Day Moving Average 13.5706
50-Day Moving Average 12.6463
20-Day Moving Average 13.686
10-Day Moving Average 12.485
Average True Range 1.1388
ADX 19.96
+DI 17.3195
-DI 21.0024
Chandelier Exit (Long, 3 ATRs ) 13.0836
Chandelier Exit (Short, 3 ATRs ) 14.8164
Upper Bollinger Band 16.5264
Lower Bollinger Band 10.8456
Percent B (%b) 0.1
BandWidth 41.50811
MACD Line -0.4555
MACD Signal Line -0.0694
MACD Histogram -0.386
Fundamentals Value
Market Cap 348.01 Million
Num Shares 30.5 Million
EPS -472.48
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.33
Resistance 3 (R3) 12.43 12.23 12.18
Resistance 2 (R2) 12.23 11.99 12.18 12.12
Resistance 1 (R1) 11.81 11.84 11.71 11.71 12.07
Pivot Point 11.61 11.61 11.56 11.56 11.61
Support 1 (S1) 11.19 11.37 11.09 11.09 10.73
Support 2 (S2) 10.99 11.22 10.94 10.68
Support 3 (S3) 10.57 10.99 10.63
Support 4 (S4) 10.47